Product Images Fulvestrant
View Photos of Packaging, Labels & Appearance
- Figure-1 - fulvestrant room nvp 01
- Figure-2 - fulvestrant room nvp 02
- Figure 3.jpg - fulvestrant room nvp 03
- Figure 4.jpg - fulvestrant room nvp 04
- Figure 5.jpg - fulvestrant room nvp 05
- structural formula - fulvestrant room nvp 06
- Figure 6.jpg - fulvestrant room nvp 07
- Figure 7.jpg - fulvestrant room nvp 08
- Figure 8.jpg - fulvestrant room nvp 09
- Figure-9 - fulvestrant room nvp 10
- Figure-10 - fulvestrant room nvp 11
- Figure 11.jpg - fulvestrant room nvp 12
- Figure 12.jpg - fulvestrant room nvp 13
- Fig_13.jpg - fulvestrant room nvp 14
- Fig_14.jpg - fulvestrant room nvp 15
- carton - fulvestrant room nvp 16
Product Label Images
The following 16 images provide visual information about the product associated with Fulvestrant NDC 0781-9055 by Sandoz Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 6.jpg - fulvestrant room nvp 07

Proportion of patients progression free and the Progression Free Survival (ITT Population) was evaluated for two doses of Fulvestrant: 250 mg and 500 mg. The number of patients at risk were 374 for Fulvestrant 250 mg and 362 for Fulvestrant 500 mg. The time in months was also provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.